ABACAVIR SULFATE

ABACAVIR SULFATE was reported 9742 times

ABACAVIR SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 94 0.7287
1 RETROPERITONEAL DISORDER 10 0.4348
2 IMMUNODEFICIENCY CONGENITAL 10 0.4000
3 TOTAL LUNG CAPACITY INCREASED 101 0.3713
4 PERITONEAL THICKENING 10 0.3571
5 GENETIC POLYMORPHISM 20 0.3509
6 DIAPHRAGMATIC APLASIA 8 0.3077
7 HIV ASSOCIATED NEPHROPATHY 15 0.2941
8 HEPATIC DISPLACEMENT 7 0.2917
9 AIDS ENCEPHALOPATHY 15 0.2586
10 HIV WASTING SYNDROME 8 0.2222
11 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 8 0.2162
12 ASTROCYTOMA MALIGNANT 20 0.1942
13 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 101 0.1931
14 ISOIMMUNE HAEMOLYTIC DISEASE 7 0.1842
15 CSF HIV ESCAPE SYNDROME 24 0.1739
16 ERYTHEMA ELEVATUM DIUTINUM 8 0.1739
17 MITOCHONDRIAL TOXICITY 138 0.1681
18 LIPODYSTROPHY ACQUIRED 286 0.1346
19 HIV VIRAEMIA 28 0.1333
20 AIDS DEMENTIA COMPLEX 8 0.1311
21 TEMPERATURE REGULATION DISORDER 262 0.1175
22 CARDIAC MALPOSITION 8 0.1053
23 CONGENITAL INTESTINAL MALFORMATION 12 0.1034
24 VIRAL MUTATION IDENTIFIED 358 0.0971
25 FOETAL GROWTH ABNORMALITY 15 0.0955
26 AIDS RELATED COMPLICATION 6 0.0923
27 MITOCHONDRIAL MYOPATHY 20 0.0917
28 VIROLOGIC FAILURE 490 0.0910
29 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 10 0.0901
30 IMMUNE RECONSTITUTION SYNDROME 102 0.0790
31 DANDY-WALKER SYNDROME 19 0.0734
32 CORONARY OSTIAL STENOSIS 8 0.0635
33 FACIAL WASTING 16 0.0595
34 MITOCHONDRIAL CYTOPATHY 25 0.0568
35 FOETAL DEATH 292 0.0563
36 CRYSTAL URINE 9 0.0563
37 BONE DEMINERALISATION 56 0.0529
38 MACROCEPHALY 20 0.0515
39 LIPOATROPHY 47 0.0494
40 POLYDACTYLY 57 0.0491
41 HYPOMANIA 175 0.0475
42 BLOOD HIV RNA INCREASED 86 0.0474
43 FOOD ALLERGY 362 0.0469
44 ATRIOVENTRICULAR SEPTAL DEFECT 22 0.0468
45 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 13 0.0468
46 RENAL ANEURYSM 11 0.0458
47 JAUNDICE CHOLESTATIC 159 0.0450
48 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 223 0.0447
49 POST TRANSPLANT DISTAL LIMB SYNDROME 9 0.0443
50 IIIRD NERVE PARESIS 8 0.0440
51 KAPOSI'S SARCOMA 22 0.0438
52 NEPHROANGIOSCLEROSIS 7 0.0435
53 BONE METABOLISM DISORDER 13 0.0432
54 PATHOGEN RESISTANCE 386 0.0423
55 GASTROSCHISIS 20 0.0420
56 ACQUIRED IMMUNODEFICIENCY SYNDROME 21 0.0405
57 FAT REDISTRIBUTION 9 0.0388
58 CD4 LYMPHOCYTES INCREASED 9 0.0386
59 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 7 0.0385
60 FANCONI SYNDROME ACQUIRED 67 0.0381
61 DIASTASIS RECTI ABDOMINIS 6 0.0373
62 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 10 0.0369
63 GRAFT DYSFUNCTION 10 0.0351
64 CHOROIDITIS 13 0.0348
65 BACTERIAL PYELONEPHRITIS 11 0.0327
66 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
67 MENINGOMYELOCELE 19 0.0317
68 DEFORMITY THORAX 6 0.0311
69 CD4 LYMPHOCYTES DECREASED 66 0.0308
70 PORTAL VENOUS GAS 11 0.0303
71 RENAL TUBULAR DYSFUNCTION 17 0.0301
72 MESENTERIC ARTERY THROMBOSIS 11 0.0286
73 NEURODEVELOPMENTAL DISORDER 19 0.0281
74 HIV INFECTION 82 0.0272
75 IMMUNODEFICIENCY 389 0.0261
76 OPHTHALMOPLEGIA 40 0.0253
77 NODULAR REGENERATIVE HYPERPLASIA 16 0.0249
78 TRISOMY 21 30 0.0238
79 CUSHING'S SYNDROME 16 0.0230
80 RHINITIS ALLERGIC 102 0.0229
81 OVARIAN FAILURE 12 0.0224
82 COELIAC DISEASE 219 0.0223
83 MENINGITIS TUBERCULOUS 12 0.0215
84 SARCOIDOSIS 101 0.0212
85 LIPOHYPERTROPHY 13 0.0209
86 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 7 0.0209
87 ANAEMIA NEONATAL 10 0.0207
88 GRAFT INFECTION 7 0.0206
89 NASAL POLYPS 101 0.0205
90 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 22 0.0203
91 INFECTIVE ANEURYSM 10 0.0202
92 SCHIZOPHRENIA 242 0.0199
93 FANCONI SYNDROME 28 0.0198
94 DYSLIPIDAEMIA 100 0.0197
95 MULTIPLE-DRUG RESISTANCE 61 0.0197
96 RETINAL TOXICITY 20 0.0194
97 CEREBRAL TOXOPLASMOSIS 18 0.0193
98 CALCULUS URINARY 29 0.0188
99 EXOMPHALOS 10 0.0186
100 GENE MUTATION 36 0.0182
101 PRESCRIBED OVERDOSE 351 0.0181
102 CENTRAL NERVOUS SYSTEM INFLAMMATION 6 0.0181
103 PLAGIOCEPHALY 9 0.0180
104 BURSITIS 219 0.0180
105 NEURAL TUBE DEFECT 13 0.0179
106 ABDOMINAL SEPSIS 15 0.0170
107 GLYCOSURIA 23 0.0170
108 RENAL TUBULAR DISORDER 46 0.0163
109 ENTEROVIRUS INFECTION 14 0.0162
110 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 17 0.0160
111 MENINGITIS CRYPTOCOCCAL 28 0.0160
112 CYTOMEGALOVIRUS CHORIORETINITIS 31 0.0159
113 LIFE EXPECTANCY SHORTENED 9 0.0159
114 BRONCHIECTASIS 106 0.0157
115 ANHEDONIA 412 0.0157
116 GENOTYPE DRUG RESISTANCE TEST POSITIVE 16 0.0156
117 PORTAL HYPERTENSION 48 0.0155
118 PLEOCYTOSIS 9 0.0155
119 SYPHILIS 11 0.0151
120 HYPERLACTACIDAEMIA 40 0.0149
121 PANCREATITIS RELAPSING 12 0.0147
122 ANAEMIA OF CHRONIC DISEASE 13 0.0144
123 VIRAL LOAD INCREASED 55 0.0142
124 DELAYED GRAFT FUNCTION 10 0.0141
125 DRUG RESISTANCE 358 0.0139
126 SUPERINFECTION BACTERIAL 11 0.0139
127 EYELID PTOSIS 141 0.0139
128 CONGENITAL MUSCULOSKELETAL ANOMALY 6 0.0136
129 ANOGENITAL WARTS 12 0.0135
130 CRYPTOSPORIDIOSIS INFECTION 7 0.0133
131 BLOOD MAGNESIUM INCREASED 12 0.0133
132 RENAL TUBULAR ACIDOSIS 29 0.0133
133 CONGENITAL FOOT MALFORMATION 6 0.0132
134 PNEUMOCYSTIS JIROVECI PNEUMONIA 29 0.0130
135 CARDIAC MURMUR 112 0.0129
136 CHRONIC ALLOGRAFT NEPHROPATHY 10 0.0128
137 ECONOMIC PROBLEM 193 0.0127
138 BLOOD LACTIC ACID INCREASED 66 0.0125
139 BLOOD AMYLASE INCREASED 21 0.0123
140 GRAFT COMPLICATION 7 0.0119
141 MYCOBACTERIUM AVIUM COMPLEX INFECTION 32 0.0119
142 GENITAL RASH 17 0.0119
143 HEART TRANSPLANT REJECTION 12 0.0116
144 VIRAEMIA 16 0.0115
145 CACHEXIA 59 0.0115
146 WHITE MATTER LESION 14 0.0111
147 OSTEOMALACIA 17 0.0110
148 HYPERTRIGLYCERIDAEMIA 63 0.0108
149 OESOPHAGEAL CANDIDIASIS 42 0.0105
150 HYPERPARATHYROIDISM SECONDARY 26 0.0104
151 END STAGE RENAL DISEASE 185 0.0101
152 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 11 0.0100
153 HEPATOSPLENOMEGALY 25 0.0097
154 RENAL INFARCT 14 0.0097
155 LIPIDS ABNORMAL 7 0.0097
156 CSF PROTEIN INCREASED 8 0.0097
157 SPINA BIFIDA 20 0.0096
158 HEPATOTOXICITY 213 0.0096
159 EXPOSURE DURING PREGNANCY 591 0.0095
160 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 8 0.0095
161 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 31 0.0094
162 BLOOD CORTISOL DECREASED 6 0.0094
163 VARICES OESOPHAGEAL 28 0.0093
164 OSTEOPENIA 140 0.0092
165 BONE DEFORMITY 6 0.0089
166 OROPHARYNGEAL CANDIDIASIS 8 0.0088
167 RENAL COLIC 20 0.0088
168 OESOPHAGEAL VARICES HAEMORRHAGE 19 0.0087
169 HEPATIC ENZYME INCREASED 583 0.0085
170 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
171 GLOMERULONEPHRITIS MEMBRANOUS 10 0.0085
172 NEPHROCALCINOSIS 10 0.0084
173 COCCIDIOIDOMYCOSIS 10 0.0084
174 TOXOPLASMOSIS 9 0.0083
175 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 27 0.0083
176 CONGENITAL CYSTIC KIDNEY DISEASE 7 0.0083
177 CONTRAINDICATED PRODUCT ADMINISTERED 250 0.0082
178 FOETAL GROWTH RESTRICTION 50 0.0082
179 BLOOD BILIRUBIN INCREASED 220 0.0081
180 STILLBIRTH 39 0.0081
181 SPEECH DISORDER DEVELOPMENTAL 23 0.0080
182 METABOLIC SYNDROME 13 0.0079
183 HISTOPLASMOSIS 14 0.0079
184 LIVE BIRTH 66 0.0079
185 CHOLELITHIASIS 258 0.0079
186 PORTAL VEIN THROMBOSIS 25 0.0077
187 MEGACOLON 12 0.0076
188 PRURIGO 7 0.0076
189 PNEUMONIA INFLUENZAL 9 0.0076
190 ASTERIXIS 8 0.0075
191 UPPER RESPIRATORY TRACT INFECTION 343 0.0074
192 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 61 0.0074
193 BLOOD BICARBONATE DECREASED 14 0.0074
194 CYTOMEGALOVIRUS COLITIS 17 0.0074
195 DECREASED IMMUNE RESPONSIVENESS 72 0.0073
196 INFERTILITY 11 0.0073
197 HEPATIC FIBROSIS 25 0.0073
198 GINGIVAL HYPERTROPHY 11 0.0072
199 RASH ERYTHEMATOUS 345 0.0072
200 RENAL ATROPHY 9 0.0072
201 GENITAL HERPES 11 0.0072
202 CLEFT LIP AND PALATE 8 0.0072
203 GLUCOSE URINE PRESENT 9 0.0071
204 OPPORTUNISTIC INFECTION 13 0.0070
205 HYPERTRICHOSIS 13 0.0070
206 SICK SINUS SYNDROME 8 0.0070
207 FAT TISSUE INCREASED 10 0.0069
208 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 11 0.0069
209 GENERALISED ANXIETY DISORDER 10 0.0068
210 POSTPARTUM HAEMORRHAGE 9 0.0067
211 NEPHROPATHY TOXIC 75 0.0067
212 ATTENTION DEFICIT HYPERACTIVITY DISORDER 28 0.0066
213 HEPATITIS B 40 0.0066
214 LUNG NEOPLASM 28 0.0065
215 RENAL TUBULAR NECROSIS 64 0.0065
216 HYPERBILIRUBINAEMIA 66 0.0064
217 PSYCHOTIC DISORDER 188 0.0064
218 MYELOPATHY 12 0.0063
219 HISTOPLASMOSIS DISSEMINATED 10 0.0063
220 ARNOLD-CHIARI MALFORMATION 6 0.0063
221 OCULAR ICTERUS 27 0.0062
222 TREATMENT FAILURE 514 0.0062
223 ANAL CANCER 6 0.0062
224 PARAPARESIS 11 0.0062
225 PSYCHIATRIC DECOMPENSATION 12 0.0061
226 HYPERLIPIDAEMIA 73 0.0061
227 RENAL TRANSPLANT 22 0.0061
228 HYDROCEPHALUS 33 0.0061
229 DISSEMINATED TUBERCULOSIS 15 0.0058
230 ENCEPHALITIS VIRAL 7 0.0057
231 TRANSPLANT REJECTION 46 0.0057
232 XEROSIS 7 0.0057
233 ATYPICAL MYCOBACTERIAL INFECTION 8 0.0057
234 PULMONARY TUBERCULOSIS 24 0.0056
235 FLUID RETENTION 285 0.0056
236 NEPHROPATHY 52 0.0056
237 NEPHRITIS INTERSTITIAL 7 0.0055
238 MICROCEPHALY 7 0.0055
239 FOETAL EXPOSURE DURING PREGNANCY 441 0.0054
240 HYPOPHOSPHATAEMIA 40 0.0054
241 NEPHROGENIC ANAEMIA 25 0.0054
242 LYMPHADENITIS 13 0.0054
243 PROTEINURIA 102 0.0054
244 NON-HODGKIN'S LYMPHOMA 7 0.0053
245 OSTEOPOROSIS 220 0.0053
246 HYPERPARATHYROIDISM 11 0.0053
247 INFUSION RELATED REACTION 353 0.0053
248 SECONDARY ADRENOCORTICAL INSUFFICIENCY 8 0.0053
249 PRE-ECLAMPSIA 25 0.0053
250 HERPES VIRUS INFECTION 30 0.0052
251 ENTEROCOCCAL INFECTION 25 0.0052
252 ANAEMIA MACROCYTIC 11 0.0051
253 CYTOLYTIC HEPATITIS 17 0.0051
254 CHRONIC KIDNEY DISEASE 385 0.0051
255 NEONATAL DISORDER 8 0.0050
256 INTERMITTENT CLAUDICATION 8 0.0050
257 HEPATITIS TOXIC 13 0.0050
258 HEPATITIS CHOLESTATIC 30 0.0050
259 LUNG CANCER METASTATIC 14 0.0049
260 COMPLICATIONS OF TRANSPLANTED KIDNEY 11 0.0048
261 LYMPH NODE PAIN 9 0.0048
262 SMALL FOR DATES BABY 24 0.0048
263 TALIPES 15 0.0048
264 INSULIN RESISTANCE 10 0.0048
265 STRABISMUS 14 0.0048
266 MYOPATHY 41 0.0047
267 TREATMENT NONCOMPLIANCE 258 0.0047
268 BONE DENSITY DECREASED 147 0.0047
269 QUALITY OF LIFE DECREASED 62 0.0046
270 DIPLOPIA 120 0.0046
271 SPINAL CORD INJURY 8 0.0046
272 PREMATURE SEPARATION OF PLACENTA 7 0.0045
273 HEPATIC NECROSIS 17 0.0045
274 INDURATION 8 0.0045
275 TRANSPLANT FAILURE 11 0.0045
276 ENCEPHALITIS 31 0.0045
277 BK VIRUS INFECTION 15 0.0044
278 ORAL CANDIDIASIS 58 0.0044
279 RENAL IMPAIRMENT 362 0.0043
280 HEPATITIS C 52 0.0043
281 HEPATOMEGALY 42 0.0043
282 DECREASED ACTIVITY 46 0.0043
283 ABORTION INDUCED 40 0.0042
284 DIABETES MELLITUS NON-INSULIN-DEPENDENT 6 0.0041
285 LIVER TRANSPLANT 15 0.0041
286 GLOMERULONEPHRITIS 10 0.0041
287 HEPATITIS FULMINANT 12 0.0040
288 KIDNEY FIBROSIS 7 0.0040
289 INTENTIONAL PRODUCT MISUSE 351 0.0040
290 THROMBOCYTOPENIA 447 0.0040
291 BLOOD URIC ACID INCREASED 23 0.0040
292 HEPATIC ENCEPHALOPATHY 37 0.0040
293 PANCREATIC FAILURE 7 0.0040
294 CAESAREAN SECTION 46 0.0039
295 DUODENITIS 12 0.0039
296 LIVER TRANSPLANT REJECTION 7 0.0039
297 EMOTIONAL DISTRESS 465 0.0038
298 GAMMA-GLUTAMYLTRANSFERASE INCREASED 84 0.0038
299 CORONARY ARTERY STENOSIS 19 0.0038
300 AREFLEXIA 10 0.0037
301 PREMATURE BABY 112 0.0037
302 CRYPTOCOCCOSIS 6 0.0037
303 ACUTE HEPATIC FAILURE 50 0.0037
304 HYPOREFLEXIA 7 0.0036
305 ATROPHY 7 0.0036
306 VITAMIN D DEFICIENCY 35 0.0036
307 PYELONEPHRITIS ACUTE 7 0.0036
308 BLOOD PHOSPHORUS DECREASED 13 0.0036
309 BLOOD ALKALINE PHOSPHATASE INCREASED 88 0.0035
310 PREMATURE LABOUR 20 0.0035
311 APHTHOUS STOMATITIS 8 0.0035
312 BLOOD CREATININE INCREASED 224 0.0034
313 MULTIPLE FRACTURES 56 0.0034
314 HYPERURICAEMIA 14 0.0034
315 BRAIN OEDEMA 43 0.0034
316 LOW BIRTH WEIGHT BABY 27 0.0034
317 NEPHROTIC SYNDROME 23 0.0034
318 ASPERGILLUS INFECTION 22 0.0033
319 BLOOD IMMUNOGLOBULIN E INCREASED 8 0.0033
320 RENAL FAILURE 438 0.0033
321 POLYDIPSIA 13 0.0033
322 PATENT DUCTUS ARTERIOSUS 13 0.0033
323 CEREBRAL ATROPHY 13 0.0033
324 HEPATIC CIRRHOSIS 61 0.0032
325 HERPES SIMPLEX 21 0.0032
326 DRUG TOXICITY 44 0.0032
327 BLOOD TRIGLYCERIDES INCREASED 57 0.0032
328 LEUKOENCEPHALOPATHY 12 0.0032
329 GLUCOSE TOLERANCE IMPAIRED 19 0.0032
330 DERMATITIS EXFOLIATIVE 16 0.0032
331 GLOMERULAR FILTRATION RATE DECREASED 39 0.0032
332 SPLENOMEGALY 37 0.0032
333 JOINT SWELLING 379 0.0031
334 ACUTE CORONARY SYNDROME 26 0.0031
335 RENAL FAILURE ACUTE 133 0.0031
336 JAUNDICE 84 0.0031
337 RENAL FAILURE CHRONIC 24 0.0031
338 DEPRESSIVE SYMPTOM 11 0.0031
339 DRUG INTOLERANCE 300 0.0031
340 HEPATOCELLULAR DAMAGE 7 0.0031
341 HYPERHIDROSIS 399 0.0031
342 DRUG INTERACTION 491 0.0031
343 PROCEDURAL HAEMORRHAGE 12 0.0031
344 LYMPHOCYTE COUNT INCREASED 10 0.0031
345 CELL DEATH 6 0.0030
346 OSTEONECROSIS 99 0.0030
347 HYPERCHOLESTEROLAEMIA 29 0.0030
348 ASTHMA 336 0.0030
349 ADRENAL INSUFFICIENCY 36 0.0030
350 RHEUMATOID ARTHRITIS 335 0.0029
351 HYDRONEPHROSIS 22 0.0029
352 DRUG EXPOSURE DURING PREGNANCY 99 0.0029
353 LYMPHADENOPATHY 103 0.0029
354 LACTIC ACIDOSIS 94 0.0029
355 HYPERSENSITIVITY 538 0.0029
356 CAROTID ARTERY STENOSIS 10 0.0029
357 ALANINE AMINOTRANSFERASE ABNORMAL 6 0.0028
358 THROMBOTIC THROMBOCYTOPENIC PURPURA 10 0.0028
359 LEFT VENTRICULAR DYSFUNCTION 19 0.0028
360 CUSHINGOID 9 0.0028
361 NEUROLOGICAL SYMPTOM 16 0.0028
362 FOOT FRACTURE 53 0.0028
363 SOCIAL AVOIDANT BEHAVIOUR 16 0.0028
364 PREGNANCY 55 0.0027
365 MATERNAL DRUGS AFFECTING FOETUS 21 0.0027
366 DIABETIC NEPHROPATHY 6 0.0027
367 TUBULOINTERSTITIAL NEPHRITIS 51 0.0027
368 PARADOXICAL DRUG REACTION 10 0.0027
369 HYPERTENSION 575 0.0027
370 HIGH DENSITY LIPOPROTEIN DECREASED 9 0.0027
371 HEPATITIS 69 0.0027
372 HISTIOCYTOSIS HAEMATOPHAGIC 8 0.0027
373 CENTRAL NERVOUS SYSTEM LESION 37 0.0027
374 ODYNOPHAGIA 16 0.0027
375 SPINAL COMPRESSION FRACTURE 22 0.0027
376 PHARYNGOLARYNGEAL PAIN 14 0.0026
377 BRONCHOPNEUMONIA 9 0.0026
378 PROTEIN URINE PRESENT 13 0.0026
379 RASH MACULO-PAPULAR 58 0.0026
380 RECTAL CANCER 8 0.0026
381 LOW DENSITY LIPOPROTEIN INCREASED 20 0.0026
382 LUNG NEOPLASM MALIGNANT 106 0.0026
383 BLOOD PHOSPHORUS INCREASED 7 0.0026
384 MYOSITIS 23 0.0026
385 CLONUS 7 0.0026
386 ARTERIOSCLEROSIS 24 0.0025
387 INTESTINAL ISCHAEMIA 14 0.0025
388 MACULOPATHY 9 0.0025
389 PYREXIA 863 0.0025
390 RETCHING 53 0.0025
391 ILEUS PARALYTIC 11 0.0025
392 BACTERIAL SEPSIS 8 0.0025
393 PERIPHERAL VENOUS DISEASE 10 0.0024
394 ATAXIA 29 0.0024
395 METABOLIC ACIDOSIS 78 0.0024
396 TRANSAMINASES INCREASED 54 0.0024
397 DRUG LEVEL INCREASED 40 0.0024
398 EXPOSURE DURING BREAST FEEDING 8 0.0024
399 NORMAL NEWBORN 13 0.0024
400 DRUG LEVEL DECREASED 24 0.0024
401 INTRACRANIAL PRESSURE INCREASED 13 0.0023
402 HAEMOLYSIS 18 0.0023
403 NORMOCHROMIC NORMOCYTIC ANAEMIA 7 0.0023
404 LEUKOPENIA 116 0.0023
405 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
406 NERVOUS SYSTEM DISORDER 72 0.0023
407 ACUTE MYOCARDIAL INFARCTION 68 0.0023
408 MATERNAL EXPOSURE DURING PREGNANCY 205 0.0023
409 GUILLAIN-BARRE SYNDROME 11 0.0023
410 HEPATIC STEATOSIS 42 0.0023
411 BLOOD CREATININE DECREASED 7 0.0022
412 STAPHYLOCOCCAL SEPSIS 11 0.0022
413 PULMONARY HYPERTENSION 46 0.0022
414 CONGENITAL ANOMALY 17 0.0022
415 BONE LOSS 33 0.0022
416 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 114 0.0022
417 ACUTE KIDNEY INJURY 334 0.0022
418 NEPHROLITHIASIS 100 0.0022
419 PHARYNGITIS 27 0.0022
420 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
421 POLYNEUROPATHY 26 0.0022
422 LYMPHOEDEMA 15 0.0022
423 NEUROTOXICITY 38 0.0022
424 AMYLASE INCREASED 8 0.0022
425 PATHOLOGICAL FRACTURE 11 0.0022
426 ALANINE AMINOTRANSFERASE INCREASED 132 0.0021
427 CHOLESTASIS 41 0.0021
428 MUSCLE ATROPHY 27 0.0021
429 ASPARTATE AMINOTRANSFERASE INCREASED 113 0.0021
430 FAILURE TO THRIVE 11 0.0021
431 PRODUCT USE ISSUE 398 0.0021
432 CYTOMEGALOVIRUS INFECTION 35 0.0021
433 PSEUDOMONAS INFECTION 18 0.0021
434 PNEUMOCYSTIS JIROVECII PNEUMONIA 21 0.0021
435 BLOOD LACTATE DEHYDROGENASE INCREASED 33 0.0021
436 PYELONEPHRITIS 18 0.0021
437 PSORIASIS 271 0.0021
438 TOOTH LOSS 43 0.0021
439 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 99 0.0021
440 CORONARY ARTERY DISEASE 62 0.0020
441 AGRANULOCYTOSIS 38 0.0020
442 AUTOIMMUNE HAEMOLYTIC ANAEMIA 7 0.0020
443 NAIL DISCOLOURATION 8 0.0020
444 APLASIA PURE RED CELL 7 0.0020
445 PANCREATIC DISORDER 10 0.0020
446 GRANULOMA 7 0.0020
447 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 52 0.0020
448 HYPERPHAGIA 8 0.0020
449 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
450 MUSCLE HAEMORRHAGE 8 0.0020
451 TACHYPNOEA 27 0.0020
452 HAND FRACTURE 14 0.0020
453 ABORTION SPONTANEOUS 79 0.0020
454 ANAEMIA 376 0.0020
455 POLYURIA 16 0.0020
456 PREMATURE DELIVERY 31 0.0019
457 LYMPHOMA 30 0.0019
458 SKELETAL INJURY 20 0.0019
459 HEMIPLEGIA 16 0.0019
460 TIBIA FRACTURE 9 0.0019
461 MAJOR DEPRESSION 14 0.0019
462 TORSADE DE POINTES 15 0.0019
463 BLOOD CREATINE PHOSPHOKINASE INCREASED 55 0.0019
464 ASCITES 56 0.0019
465 DIALYSIS 27 0.0019
466 COLITIS MICROSCOPIC 9 0.0019
467 SLEEP TERROR 8 0.0019
468 HAEMOLYTIC ANAEMIA 17 0.0019
469 ANOREXIA 24 0.0019
470 HEPATIC FAILURE 56 0.0019
471 LIVER FUNCTION TEST ABNORMAL 54 0.0019
472 MULTI-ORGAN FAILURE 32 0.0018
473 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
474 RENAL DISORDER 86 0.0018
475 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
476 WRIST FRACTURE 22 0.0018
477 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
478 INFECTION 264 0.0018
479 WHEEZING 107 0.0018
480 RHINOVIRUS INFECTION 7 0.0018
481 CARDIOPULMONARY FAILURE 7 0.0018
482 GASTROOESOPHAGEAL REFLUX DISEASE 144 0.0018
483 HAEMODIALYSIS 15 0.0018
484 OLIGURIA 11 0.0018
485 PAPILLOEDEMA 8 0.0018
486 HEPATIC FUNCTION ABNORMAL 66 0.0018
487 RENAL CYST 14 0.0018
488 BLOOD THYROID STIMULATING HORMONE DECREASED 8 0.0018
489 ABSCESS 28 0.0018
490 PANCYTOPENIA 98 0.0018
491 DRUG-INDUCED LIVER INJURY 55 0.0018
492 OVERDOSE 374 0.0017
493 LIPASE INCREASED 13 0.0017
494 RETINAL HAEMORRHAGE 12 0.0017
495 CARDIAC TAMPONADE 8 0.0017
496 ANXIETY 476 0.0017
497 STRESS FRACTURE 9 0.0017
498 FAECAL INCONTINENCE 8 0.0017
499 EOSINOPHILIA 29 0.0017
500 HEMIPARESIS 28 0.0017
501 RENAL INJURY 49 0.0016
502 RASH GENERALISED 42 0.0016
503 NECROSIS 9 0.0016
504 RENAL PAIN 17 0.0016
505 LIVER DISORDER 71 0.0016
506 BRAIN INJURY 16 0.0016
507 PANCREATITIS 84 0.0016
508 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
509 MYOCARDIAL ISCHAEMIA 18 0.0016
510 TOXIC ENCEPHALOPATHY 8 0.0016
511 HAEMATOTOXICITY 15 0.0016
512 CLAVICLE FRACTURE 6 0.0016
513 EXERCISE TOLERANCE DECREASED 9 0.0016
514 CEREBRAL ISCHAEMIA 8 0.0016
515 METABOLIC DISORDER 9 0.0015
516 SUSPECTED OFF LABEL USE 7 0.0015
517 CERVIX CARCINOMA 6 0.0015
518 APLASTIC ANAEMIA 8 0.0015
519 SKIN LESION 42 0.0015
520 LUMBAR VERTEBRAL FRACTURE 7 0.0015
521 ISCHAEMIA 7 0.0015
522 HYPERTHYROIDISM 22 0.0015
523 AZOTAEMIA 6 0.0015
524 CANDIDIASIS 6 0.0015
525 CEREBRAL DISORDER 11 0.0015
526 PANCREATITIS ACUTE 33 0.0015
527 SUBCUTANEOUS ABSCESS 7 0.0015
528 ECCHYMOSIS 10 0.0015
529 PAIN 892 0.0015
530 CHOLANGITIS 9 0.0015
531 MYOCLONUS 17 0.0014
532 ENCEPHALOPATHY 35 0.0014
533 ANKLE FRACTURE 22 0.0014
534 INCONTINENCE 15 0.0014
535 HYPERVOLAEMIA 7 0.0014
536 HYPOALBUMINAEMIA 11 0.0014
537 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
538 CHOLECYSTITIS ACUTE 8 0.0014
539 HYPONATRAEMIA 79 0.0014
540 RASH 609 0.0014
541 RHABDOMYOLYSIS 58 0.0014
542 COAGULOPATHY 23 0.0014
543 EYELID OEDEMA 16 0.0014
544 GASTROENTERITIS 20 0.0014
545 DYSPHEMIA 6 0.0014
546 IMMUNE SYSTEM DISORDER 18 0.0014
547 FEMORAL NECK FRACTURE 7 0.0014
548 RIB FRACTURE 28 0.0014
549 BLOOD CREATINE INCREASED 6 0.0014
550 STEVENS-JOHNSON SYNDROME 30 0.0013
551 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
552 PROTHROMBIN TIME PROLONGED 8 0.0013
553 NEUROPATHY PERIPHERAL 126 0.0013
554 JOINT DISLOCATION 14 0.0013
555 CORONARY ARTERY OCCLUSION 18 0.0013
556 HYPERKALAEMIA 46 0.0013
557 ACIDOSIS 10 0.0013
558 CARDIOMEGALY 16 0.0013
559 BEHAVIOUR DISORDER 7 0.0013
560 ELECTROLYTE IMBALANCE 15 0.0013
561 EXTRASYSTOLES 9 0.0013
562 BACK PAIN 298 0.0013
563 SKIN HYPERPIGMENTATION 11 0.0013
564 OEDEMA PERIPHERAL 155 0.0013
565 BLOOD UREA INCREASED 21 0.0013
566 ERYTHEMA 257 0.0012
567 VOMITING 582 0.0012
568 HYPOKALAEMIA 57 0.0012
569 SUDDEN DEATH 13 0.0012
570 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
571 BLOOD SODIUM DECREASED 23 0.0012
572 PNEUMONIA BACTERIAL 11 0.0012
573 SKIN MASS 8 0.0012
574 HAEMATURIA 41 0.0012
575 ULCER 19 0.0012
576 TOXIC SKIN ERUPTION 12 0.0012
577 HYPOTHERMIA 12 0.0012
578 CONSTIPATION 254 0.0012
579 MALNUTRITION 13 0.0012
580 ANURIA 10 0.0012
581 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0012
582 VENTRICULAR EXTRASYSTOLES 12 0.0012
583 HYPERGLYCAEMIA 42 0.0012
584 CATATONIA 6 0.0011
585 MYOCARDITIS 13 0.0011
586 IMMUNOSUPPRESSION 10 0.0011
587 LUNG INFILTRATION 10 0.0011
588 DYSSTASIA 33 0.0011
589 MULTIPLE ORGAN DYSFUNCTION SYNDROME 32 0.0011
590 DEPRESSION 257 0.0011
591 DRUG ERUPTION 20 0.0011
592 PARKINSONISM 11 0.0011
593 BLOOD DISORDER 9 0.0011
594 CARDIOTOXICITY 10 0.0011
595 DIABETES MELLITUS 84 0.0011
596 SPINAL FRACTURE 22 0.0011
597 ESCHERICHIA INFECTION 9 0.0011
598 PNEUMONIA 354 0.0011
599 EOSINOPHIL COUNT INCREASED 9 0.0011
600 MOTOR DYSFUNCTION 11 0.0011
601 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
602 SYNOVITIS 19 0.0011
603 HAEMODYNAMIC INSTABILITY 8 0.0010
604 IMPAIRED WORK ABILITY 22 0.0010
605 RESPIRATORY FAILURE 75 0.0010
606 AMENORRHOEA 18 0.0010
607 SPINAL OSTEOARTHRITIS 9 0.0010
608 BLOOD TESTOSTERONE DECREASED 7 0.0010
609 PERITONITIS 21 0.0010
610 BACTERAEMIA 12 0.0010
611 DISEASE RECURRENCE 48 0.0010
612 HYPERTRANSAMINASAEMIA 7 0.0010
613 FRACTURE 19 0.0010
614 ANAL INCONTINENCE 9 0.0010
615 DEVELOPMENTAL DELAY 9 0.0010
616 MYOCARDIAL INFARCTION 174 0.0010
617 PAPULE 7 0.0010
618 CONDITION AGGRAVATED 302 0.0010
619 NEUTROPENIA 135 0.0010
620 DYSPHAGIA 94 0.0010
621 HEPATOCELLULAR INJURY 14 0.0010
622 ANGINA PECTORIS 28 0.0010
623 STATUS EPILEPTICUS 11 0.0010
624 HYPERAESTHESIA 8 0.0010
625 GENERALISED OEDEMA 12 0.0010
626 DIARRHOEA HAEMORRHAGIC 9 0.0010
627 RASH PUSTULAR 7 0.0010
628 ELECTROCARDIOGRAM QT PROLONGED 34 0.0009
629 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
630 AFFECT LABILITY 9 0.0009
631 BONE MARROW FAILURE 19 0.0009
632 HIP FRACTURE 30 0.0009
633 METASTASES TO CENTRAL NERVOUS SYSTEM 12 0.0009
634 APHASIA 28 0.0009
635 ANGINA UNSTABLE 6 0.0009
636 PERICARDIAL EFFUSION 21 0.0009
637 TOOTH FRACTURE 10 0.0009
638 APPETITE DISORDER 6 0.0009
639 ABDOMINAL PAIN 210 0.0009
640 HEADACHE 561 0.0009
641 BLOOD CALCIUM DECREASED 10 0.0009
642 TOXICITY TO VARIOUS AGENTS 149 0.0009
643 BLOOD ALBUMIN DECREASED 7 0.0009
644 BLOOD CHOLESTEROL INCREASED 41 0.0009
645 SENSORY LOSS 7 0.0009
646 ABNORMAL DREAMS 24 0.0009
647 HAEMATEMESIS 22 0.0009
648 NIGHTMARE 30 0.0009
649 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
650 GENERAL PHYSICAL HEALTH DETERIORATION 100 0.0009
651 PETECHIAE 9 0.0009
652 DUODENAL ULCER 6 0.0008
653 CARDIAC FAILURE 68 0.0008
654 DEVICE RELATED INFECTION 13 0.0008
655 PNEUMONIA ASPIRATION 21 0.0008
656 NAUSEA 661 0.0008
657 OESOPHAGITIS 9 0.0008
658 THERAPY NON-RESPONDER 37 0.0008
659 CONVULSION 47 0.0008
660 MYALGIA 139 0.0008
661 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
662 LIVER INJURY 20 0.0008
663 NERVE INJURY 9 0.0008
664 MUCOSAL INFLAMMATION 21 0.0008
665 HYPOTONIA 8 0.0008
666 GASTRITIS 21 0.0008
667 COMA 38 0.0008
668 DYSARTHRIA 30 0.0008
669 OEDEMA 43 0.0008
670 COGNITIVE DISORDER 37 0.0008
671 BODY TEMPERATURE INCREASED 16 0.0008
672 SHOCK 18 0.0008
673 LEUKOCYTOSIS 14 0.0008
674 VASCULITIS 9 0.0008
675 LUNG INFECTION 12 0.0008
676 PALLOR 21 0.0008
677 OPTIC NEURITIS 7 0.0008
678 HAEMOGLOBIN DECREASED 79 0.0008
679 NODULE 10 0.0008
680 DEAFNESS 20 0.0008
681 DERMATITIS 16 0.0008
682 SEPTIC SHOCK 33 0.0008
683 MENTAL DISORDER 33 0.0008
684 GRAND MAL CONVULSION 7 0.0008
685 PNEUMOTHORAX 12 0.0008
686 DYSPNOEA EXERTIONAL 28 0.0007
687 URINARY INCONTINENCE 22 0.0007
688 ERECTILE DYSFUNCTION 19 0.0007
689 PRURITUS GENERALISED 16 0.0007
690 BLOOD POTASSIUM INCREASED 12 0.0007
691 CEREBRAL INFARCTION 18 0.0007
692 HAEMORRHAGE INTRACRANIAL 11 0.0007
693 DYSURIA 27 0.0007
694 ACUTE RESPIRATORY FAILURE 14 0.0007
695 GOUT 13 0.0007
696 MOBILITY DECREASED 52 0.0007
697 EPILEPSY 22 0.0007
698 THROMBOTIC MICROANGIOPATHY 7 0.0007
699 HIP ARTHROPLASTY 11 0.0007
700 SEPSIS 80 0.0007
701 ATRIAL SEPTAL DEFECT 6 0.0007
702 DERMATITIS ALLERGIC 9 0.0007
703 TYPE 2 DIABETES MELLITUS 24 0.0007
704 CANDIDA INFECTION 12 0.0007
705 SKIN REACTION 10 0.0007
706 LYMPHOPENIA 10 0.0007
707 FATIGUE 550 0.0007
708 SINUS TACHYCARDIA 10 0.0007
709 UPPER LIMB FRACTURE 14 0.0007
710 SUBDURAL HAEMATOMA 10 0.0007
711 BACTERIAL INFECTION 13 0.0007
712 POLLAKIURIA 29 0.0007
713 BLOOD MAGNESIUM DECREASED 6 0.0007
714 OFF LABEL USE 603 0.0007
715 SUBARACHNOID HAEMORRHAGE 7 0.0007
716 HYPOCALCAEMIA 13 0.0007
717 TACHYCARDIA 61 0.0007
718 OSTEOARTHRITIS 29 0.0007
719 ISCHAEMIC STROKE 12 0.0007
720 FOLLICULITIS 7 0.0007
721 VENTRICULAR TACHYCARDIA 11 0.0007
722 DELIRIUM 23 0.0007
723 BONE DISORDER 12 0.0007
724 DISORIENTATION 26 0.0007
725 APPENDICITIS 6 0.0006
726 WEIGHT DECREASED 179 0.0006
727 ASTHENIA 241 0.0006
728 MUSCULOSKELETAL PAIN 33 0.0006
729 SLEEP APNOEA SYNDROME 12 0.0006
730 DIARRHOEA 405 0.0006
731 HERPES ZOSTER 36 0.0006
732 HYPOTHYROIDISM 20 0.0006
733 HYPOXIA 22 0.0006
734 MITRAL VALVE INCOMPETENCE 7 0.0006
735 RESPIRATORY DISTRESS 17 0.0006
736 SCAB 7 0.0006
737 FEMUR FRACTURE 19 0.0006
738 MENTAL STATUS CHANGES 17 0.0006
739 BEDRIDDEN 8 0.0006
740 COLITIS 23 0.0006
741 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
742 GAIT DISTURBANCE 116 0.0006
743 PLATELET COUNT DECREASED 64 0.0006
744 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
745 FACE OEDEMA 10 0.0006
746 CHOLECYSTITIS 7 0.0006
747 CEREBRAL HAEMORRHAGE 21 0.0006
748 MUSCLE RIGIDITY 7 0.0006
749 GYNAECOMASTIA 18 0.0006
750 TENDONITIS 9 0.0006
751 RASH PAPULAR 13 0.0006
752 AGGRESSION 29 0.0006
753 GASTRIC ULCER 11 0.0006
754 LABORATORY TEST ABNORMAL 17 0.0006
755 NO THERAPEUTIC RESPONSE 7 0.0006
756 COORDINATION ABNORMAL 8 0.0006
757 RASH PRURITIC 31 0.0006
758 BLOOD PRESSURE DECREASED 38 0.0006
759 GASTROINTESTINAL DISORDER 51 0.0006
760 HYPERCALCAEMIA 7 0.0006
761 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
762 ILEUS 7 0.0006
763 INFLAMMATION 29 0.0006
764 SENSORY DISTURBANCE 9 0.0006
765 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
766 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
767 C-REACTIVE PROTEIN INCREASED 20 0.0005
768 HEPATIC CYTOLYSIS 7 0.0005
769 BRADYCARDIA 29 0.0005
770 CHILLS 64 0.0005
771 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
772 ADVERSE EVENT 50 0.0005
773 URINARY RETENTION 18 0.0005
774 CONJUNCTIVITIS 10 0.0005
775 LETHARGY 31 0.0005
776 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
777 LUNG DISORDER 26 0.0005
778 METRORRHAGIA 9 0.0005
779 BLOOD URINE PRESENT 10 0.0005
780 ABASIA 13 0.0005
781 PULMONARY EMBOLISM 50 0.0005
782 CARDIO-RESPIRATORY ARREST 22 0.0005
783 FEAR 14 0.0005
784 LOWER LIMB FRACTURE 10 0.0005
785 PRODUCT TASTE ABNORMAL 7 0.0005
786 DECREASED APPETITE 120 0.0005
787 DELUSION 8 0.0005
788 COLD SWEAT 9 0.0005
789 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
790 HYPOAESTHESIA 76 0.0005
791 HALLUCINATION, AUDITORY 8 0.0005
792 MELAENA 11 0.0005
793 CARDIAC ARREST 40 0.0005
794 EXTRAPYRAMIDAL DISORDER 12 0.0005
795 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
796 VISUAL ACUITY REDUCED 16 0.0005
797 DEEP VEIN THROMBOSIS 31 0.0005
798 MOUTH ULCERATION 10 0.0005
799 HYPOGLYCAEMIA 23 0.0005
800 CARDIOMYOPATHY 7 0.0005
801 HYPOTENSION 94 0.0005
802 SCAR 8 0.0005
803 HAEMOPTYSIS 13 0.0005
804 ACCIDENTAL OVERDOSE 17 0.0005
805 HAEMORRHOIDS 9 0.0005
806 CHEST PAIN 85 0.0005
807 GALLBLADDER DISORDER 8 0.0004
808 THIRST 8 0.0004
809 SUICIDE ATTEMPT 27 0.0004
810 BONE PAIN 26 0.0004
811 BLINDNESS 18 0.0004
812 SLEEP DISORDER 31 0.0004
813 PANIC ATTACK 16 0.0004
814 MOVEMENT DISORDER 14 0.0004
815 ABDOMINAL PAIN LOWER 11 0.0004
816 RESPIRATORY DISORDER 13 0.0004
817 SEIZURE 50 0.0004
818 RASH MACULAR 15 0.0004
819 DEHYDRATION 57 0.0004
820 DISTURBANCE IN ATTENTION 23 0.0004
821 EYE DISORDER 14 0.0004
822 COUGH 119 0.0004
823 PHOTOSENSITIVITY REACTION 7 0.0004
824 MALAISE 184 0.0004
825 SWELLING FACE 27 0.0004
826 PRODUCT USE IN UNAPPROVED INDICATION 102 0.0004
827 PALPITATIONS 48 0.0004
828 NIGHT SWEATS 13 0.0004
829 NEOPLASM PROGRESSION 14 0.0004
830 BLOOD POTASSIUM DECREASED 12 0.0004
831 CHROMATURIA 9 0.0004
832 PLEURAL EFFUSION 24 0.0004
833 DRUG DISPENSING ERROR 6 0.0004
834 OXYGEN SATURATION DECREASED 22 0.0004
835 DISEASE PROGRESSION 46 0.0004
836 MUSCULAR WEAKNESS 44 0.0004
837 OSTEOMYELITIS 7 0.0004
838 ANGIOEDEMA 17 0.0004
839 GASTROINTESTINAL HAEMORRHAGE 32 0.0004
840 ARRHYTHMIA 18 0.0004
841 FEBRILE NEUTROPENIA 25 0.0004
842 EATING DISORDER 8 0.0004
843 BLISTER 21 0.0004
844 ABDOMINAL DISTENSION 39 0.0004
845 SUICIDAL IDEATION 34 0.0004
846 FAECES DISCOLOURED 8 0.0004
847 PAIN IN EXTREMITY 108 0.0004
848 INSOMNIA 97 0.0004
849 STAPHYLOCOCCAL INFECTION 12 0.0004
850 GLAUCOMA 7 0.0004
851 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
852 SKIN DISORDER 12 0.0004
853 LOSS OF CONSCIOUSNESS 46 0.0004
854 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
855 CONFUSIONAL STATE 58 0.0004
856 PULMONARY OEDEMA 16 0.0004
857 AGITATION 26 0.0004
858 HAEMATOCRIT DECREASED 7 0.0004
859 CIRCULATORY COLLAPSE 6 0.0004
860 DRUG INEFFECTIVE 462 0.0004
861 RED BLOOD CELL COUNT DECREASED 10 0.0003
862 SKIN ULCER 9 0.0003
863 HALLUCINATION 26 0.0003
864 NEUTROPHIL COUNT DECREASED 14 0.0003
865 DEPRESSED MOOD 18 0.0003
866 SOMNOLENCE 68 0.0003
867 DIABETIC KETOACIDOSIS 8 0.0003
868 ABNORMAL BEHAVIOUR 13 0.0003
869 LIVER FUNCTION TEST INCREASED 7 0.0003
870 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
871 POOR QUALITY SLEEP 7 0.0003
872 DYSPNOEA 184 0.0003
873 URINARY TRACT INFECTION 55 0.0003
874 ABDOMINAL PAIN UPPER 66 0.0003
875 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
876 PARAESTHESIA 50 0.0003
877 OCULAR HYPERAEMIA 15 0.0003
878 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
879 CARDIOVASCULAR DISORDER 8 0.0003
880 DEATH 269 0.0003
881 INTERSTITIAL LUNG DISEASE 15 0.0003
882 SPEECH DISORDER 16 0.0003
883 IRRITABILITY 18 0.0003
884 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
885 PRURITUS 112 0.0003
886 PRESYNCOPE 7 0.0003
887 HEART RATE DECREASED 10 0.0003
888 SKIN EXFOLIATION 24 0.0003
889 ILL-DEFINED DISORDER 17 0.0003
890 VERTIGO 17 0.0003
891 HYPOACUSIS 12 0.0003
892 RHINORRHOEA 18 0.0003
893 CEREBROVASCULAR ACCIDENT 47 0.0003
894 HYPOPHAGIA 7 0.0003
895 VIRAL INFECTION 9 0.0003
896 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
897 GAIT INABILITY 9 0.0003
898 NECK PAIN 15 0.0003
899 WEIGHT INCREASED 60 0.0003
900 CHEST DISCOMFORT 27 0.0003
901 GASTRIC DISORDER 9 0.0003
902 ARTHRALGIA 109 0.0003
903 DIZZINESS 129 0.0003
904 INFLUENZA LIKE ILLNESS 21 0.0003
905 HOSPITALISATION 39 0.0003
906 VAGINAL HAEMORRHAGE 11 0.0003
907 FEELING COLD 7 0.0003
908 PRODUCTIVE COUGH 12 0.0003
909 URTICARIA 42 0.0003
910 HAEMORRHAGE 26 0.0002
911 CRYING 9 0.0002
912 DYSPEPSIA 24 0.0002
913 HEART RATE INCREASED 24 0.0002
914 MEMORY IMPAIRMENT 33 0.0002
915 TINNITUS 11 0.0002
916 SKIN DISCOLOURATION 11 0.0002
917 ARTHROPATHY 13 0.0002
918 THERAPEUTIC RESPONSE DECREASED 14 0.0002
919 STOMATITIS 14 0.0002
920 TREMOR 38 0.0002
921 SYNCOPE 22 0.0002
922 BRONCHITIS 16 0.0002
923 EYE SWELLING 8 0.0002
924 IMPAIRED HEALING 7 0.0002
925 CARDIAC FAILURE CONGESTIVE 17 0.0002
926 OROPHARYNGEAL PAIN 19 0.0002
927 DYSGEUSIA 15 0.0002
928 MEDICATION ERROR 11 0.0002
929 DISCOMFORT 12 0.0002
930 DRUG ABUSE 16 0.0002
931 ADVERSE DRUG REACTION 17 0.0002
932 INTENTIONAL OVERDOSE 12 0.0002
933 RECTAL HAEMORRHAGE 8 0.0002
934 INTESTINAL OBSTRUCTION 7 0.0002
935 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
936 MUSCULOSKELETAL STIFFNESS 16 0.0002
937 MUSCLE SPASMS 33 0.0002
938 FEELING ABNORMAL 43 0.0002
939 ABDOMINAL DISCOMFORT 30 0.0002
940 ANGER 6 0.0002
941 FLATULENCE 10 0.0002
942 NERVOUSNESS 9 0.0002
943 INJURY 12 0.0002
944 BLOOD GLUCOSE INCREASED 32 0.0002
945 VISION BLURRED 23 0.0002
946 FLUSHING 17 0.0002
947 NASOPHARYNGITIS 30 0.0002
948 THROMBOSIS 13 0.0002
949 INFLUENZA 18 0.0002
950 CARDIAC DISORDER 15 0.0002
951 EYE PAIN 9 0.0002
952 FALL 53 0.0002
953 HOT FLUSH 12 0.0002
954 CELLULITIS 8 0.0002
955 THERAPY CESSATION 8 0.0002
956 AMNESIA 10 0.0002
957 ECZEMA 8 0.0002
958 FEELING HOT 9 0.0001
959 HAEMATOCHEZIA 8 0.0001
960 COMPLETED SUICIDE 12 0.0001
961 PRODUCT SUBSTITUTION ISSUE 8 0.0001
962 BALANCE DISORDER 12 0.0001
963 UNDERDOSE 10 0.0001
964 DRY MOUTH 11 0.0001
965 ATRIAL FIBRILLATION 13 0.0001
966 ALOPECIA 26 0.0001
967 ACNE 10 0.0001
968 DRY SKIN 17 0.0001
969 ARTHRITIS 10 0.0001
970 NO ADVERSE EVENT 23 0.0001
971 BLOOD GLUCOSE DECREASED 6 0.0001
972 BLOOD PRESSURE INCREASED 18 0.0001
973 INJECTION SITE REACTION 8 0.0001
974 BURNING SENSATION 8 0.0001
975 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
976 EPISTAXIS 8 0.0001
977 VISUAL IMPAIRMENT 13 0.0001
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
979 SWELLING 9 0.0001
980 PERIPHERAL SWELLING 14 0.0001
981 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
982 SINUSITIS 9 0.0001
983 PRODUCT DOSE OMISSION ISSUE 25 0.0001
984 MIGRAINE 8 0.0001
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
986 COVID-19 12 0.0001
987 BREAST CANCER 6 0.0001
988 CONTUSION 6 0.0001
989 INCORRECT DOSE ADMINISTERED 11 0.0000
990 DRUG DOSE OMISSION 7 0.0000